These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7501113)

  • 41. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
    Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
    Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma.
    Kuratsu JI; Seto H; Kochi M; Ushio Y
    Acta Neurochir (Wien); 1994; 131(3-4):289-93. PubMed ID: 7754837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meningioma.
    Kujas M
    Curr Opin Neurol; 1993 Dec; 6(6):882-7. PubMed ID: 8293162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods.
    Nakasu S; Li DH; Okabe H; Nakajima M; Matsuda M
    Am J Surg Pathol; 2001 Apr; 25(4):472-8. PubMed ID: 11257621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data.
    Bouillot P; Pellissier JF; Devictor B; Graziani N; Bianco N; Grisoli F; Figarella-Branger D
    J Neurosurg; 1994 Nov; 81(5):765-73. PubMed ID: 7523635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex hormone receptors in intracranial tumours and normal brain.
    Whittle IR; Hawkins RA; Miller JD
    Eur J Surg Oncol; 1987 Aug; 13(4):303-7. PubMed ID: 3622783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
    Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
    J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proliferative activity of acoustic neurilemomas without neurofibromatosis determined by monoclonal antibody MIB 1.
    Aguiar PH; Tatagiba M; Dankoweit-Timpe E; Matthies C; Samii M; Ostertag H
    Acta Neurochir (Wien); 1995; 134(1-2):35-9. PubMed ID: 7668123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
    Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
    J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen and progesterone receptors in meningiomas and gliomas.
    Georgakulias N; Singounas E; Kypriades E; Giotis J; Karvounis P
    Zentralbl Neurochir; 1993; 54(3):139-42. PubMed ID: 8237168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of embolisation of meningioma on Ki-67 proliferation index.
    Paulus W; Meixensberger J; Hofmann E; Roggendorf W
    J Clin Pathol; 1993 Sep; 46(9):876-7. PubMed ID: 8227445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
    Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
    Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
    Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
    Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hormone receptor determination in breast carcinoma tissue. Comparison of recent immunohistologic techniques with biochemical receptor testing].
    Wilkens C; Beck T; Weikel W; Brumm C; Pollow K
    Pathologe; 1995 Jul; 16(4):256-61. PubMed ID: 7667207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression.
    Nagashima G; Asai J; Suzuki R; Fujimoto T
    Brain Tumor Pathol; 2001; 18(1):1-5. PubMed ID: 11517968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunohistopathological analysis of estrogen receptors in human meningioma].
    Sawada T; Oinuma T; Saitoh M; Shinbashi M; Nishino H; Sakurai I
    Rinsho Byori; 1993 Jun; 41(6):698-702. PubMed ID: 8361037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management.
    Ohta M; Iwaki T; Kitamoto T; Takeshita I; Tateishi J; Fukui M
    Cancer; 1994 Dec; 74(12):3176-89. PubMed ID: 7982181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S; Mangia A; D'Amico C; Simone G
    Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.